Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system

[1]  S. Datta,et al.  In vitro and in vivo release of cefuroxime axetil from bioactive glass as an implantable delivery system in experimental osteomyelitis , 2009 .

[2]  Chidambaram Soundrapandian,et al.  Organic–Inorganic Composites for Bone Drug Delivery , 2009, AAPS PharmSciTech.

[3]  D. Basu,et al.  Local antibiotic delivery systems for the treatment of osteomyelitis - A review , 2009 .

[4]  A. Bandyopadhyay,et al.  Role of surface charge and wettability on early stage mineralization and bone cell-materials interactions of polarized hydroxyapatite. , 2009, Acta biomaterialia.

[5]  S. Datta,et al.  Cefuroxime-impregnated calcium phosphates as an implantable delivery system in experimental osteomyelitis , 2009 .

[6]  P. Giannoudis,et al.  Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin. , 2008, Injury.

[7]  M. Prabaharan.  Review Paper: Chitosan Derivatives as Promising Materials for Controlled Drug Delivery , 2008, Journal of biomaterials applications.

[8]  Debabrata Basu,et al.  In vivo response of porous hydroxyapatite and beta-tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffolds. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  D. Basu,et al.  Efficacy of nano-hydroxyapatite prepared by an aqueous solution combustion technique in healing bone defects of goat , 2008, Journal of veterinary science.

[10]  D. Basu,et al.  Evaluation of new porous β-tri-calcium phosphate ceramic as bone substitute in goat model , 2008 .

[11]  P. Webster.  Developing a New Generation of Bone Cements With Nanotechnology , 2008 .

[12]  D. Kohn,et al.  Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? , 2008, Acta orthopaedica.

[13]  Jun Wang,et al.  Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  Maizirwan Mel,et al.  Porous hydroxyapatite for artificial bone applications , 2007 .

[15]  Aijun Wang,et al.  A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. , 2006, Journal of biomedical materials research. Part A.

[16]  Y. Gong,et al.  Manufacture of multimicrotubule chitosan nerve conduits with novel molds and characterization in vitro. , 2006, Journal of biomedical materials research. Part A.

[17]  W. Grayson,et al.  Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. , 2006, Biomaterials.

[18]  N. Mostafa.  Characterization, thermal stability and sintering of hydroxyapatite powders prepared by different routes , 2005 .

[19]  Y. Gong,et al.  Preparation and characterization of nano-hydroxyapatite/chitosan composite scaffolds. , 2005, Journal of biomedical materials research. Part A.

[20]  G. Dubini,et al.  Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach , 2005 .

[21]  P. Layrolle,et al.  Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[22]  M. K. Sinha,et al.  Fabrication and characterization of porous hydroxyapatite ocular implant followed by anin vivo study in dogs , 2004 .

[23]  J. Ferreira,et al.  Combining Foaming and Starch Consolidation Methods to Develop Macroporous Hydroxyapatite Implants , 2003 .

[24]  J. Ferreira,et al.  New Method for the Incorporation of Soluble Bioactive Glasses to Reinforce Porous HA Structures , 2003 .

[25]  T. Tan,et al.  Insecticidal and Fungicidal Activities of Chitosan and Oligo-chitosan , 2003 .

[26]  A. Sombra,et al.  Structural properties of hydroxyapatite obtained by mechanosynthesis , 2003 .

[27]  M. Yoshimura,et al.  Low-temperature, hydrothermal transformation of aragonite to hydroxyapatite , 2002 .

[28]  A. Lebugle,et al.  Study of implantable calcium phosphate systems for the slow release of methotrexate. , 2002, Biomaterials.

[29]  J. C. Belchior,et al.  Controlled release of rhodium (II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix. , 2002, Biomaterials.

[30]  W. Mark Saltzman,et al.  Transplantation of brain cells assembled around a programmable synthetic microenvironment , 2001, Nature Biotechnology.

[31]  M. Vallet‐Regí,et al.  Colloidal processing of hydroxyapatite. , 2001, Biomaterials.

[32]  R Langer,et al.  In vitro generation of osteochondral composites. , 2000, Biomaterials.

[33]  E. Landi,et al.  Densification behaviour and mechanisms of synthetic hydroxyapatites , 2000 .

[34]  J. Rissing.  Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  E. Elsinger,et al.  Coralline hydroxyapatite bone graft substitutes. , 1996, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[36]  M. Rahaman.  Ceramic Processing and Sintering , 1995 .

[37]  V. Jansson,et al.  Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits. , 1994, Acta orthopaedica Scandinavica.

[38]  R Z LeGeros,et al.  Calcium phosphates in oral biology and medicine. , 1991, Monographs in oral science.

[39]  P. Eggli,et al.  Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. , 1988, Clinical orthopaedics and related research.

[40]  K. Bush,et al.  Beta-lactamase inhibitors from laboratory to clinic , 1988, Clinical Microbiology Reviews.

[41]  R. Holmes,et al.  A coralline hydroxyapatite bone graft substitute. Preliminary report. , 1984, Clinical orthopaedics and related research.

[42]  Robert L. Davidson,et al.  Handbook of Water Soluble Gums and Resins , 1980 .

[43]  E. White,et al.  Replamineform porous biomaterials for hard tissue implant applications. , 1975, Journal of biomedical materials research.

[44]  S F Hulbert,et al.  Tissue reaction to three ceramics of porous and non-porous structures. , 1972, Journal of biomedical materials research.

[45]  J. Klawitter,et al.  Application of porous ceramics for the attachment of load bearing internal orthopedic applications , 1971 .

[46]  B. Cullity,et al.  Elements of X-ray diffraction , 1957 .

[47]  V. Dwivedi,et al.  In Vitro Microbial Efficacy of Sulbactomax: A Novel Fixed Dose Combination of Ceftriaxone Sulbactam and Ceftriaxone Alone , 2009 .

[48]  S. Datta,et al.  Drug-eluting implants for osteomyelitis. , 2007, Critical reviews in therapeutic drug carrier systems.

[49]  Seonghun Park,et al.  Functional tissue engineering of chondral and osteochondral constructs. , 2004, Biorheology.

[50]  José M.F. Ferreira,et al.  Processing of porous ceramics by ‘starch consolidation’ , 1998 .

[51]  M. Yoshimura,et al.  Hydrothermal synthesis of biocompatible whiskers , 1994, Journal of Materials Science.

[52]  R. Z. LeGeros,et al.  1. Introduction — Scope , 1991 .

[53]  L. Hench,et al.  CRC handbook of bioactive ceramics , 1990 .

[54]  M. Ashby,et al.  Cellular solids: Structure & properties , 1988 .

[55]  J. Featherstone,et al.  Preparation, analysis, and characterization of carbonated apatites. , 1982, Calcified tissue international.

[56]  L. Alexander,et al.  X-Ray diffraction procedures for polycrystalline and amorphous materials , 1974 .

[57]  Narayanan Tr Kutty.  Assignments of some bands in the infrared spectrum of b-tricalcium phosphate , 1970 .